nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.06.2020 | Editorial

Editorial commentary to “¹⁸F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases” by Grkovski and colleagues

verfasst von: Pierre Lovinfosse, Selma Ben Mustapha, Nadia Withofs

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Grkovski M, Kohutek ZA, Schöder H, et al. ¹⁸F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases. Eur J Nucl Med Mol Imaging (2019). https://doi.org/10.1007/s00259-019-04628-6.

Patel TR, McHugh BJ, Bi WL, et al. A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol. 2011;32(10):1885–92.CrossRef

Menoux I, Armspach JP, Noel G, et al. Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: literature review. Cancer Radiother. 2016;20(8):837–45.CrossRef

O'Beirn M, Benghiat H, Meade S, et al. The Expanding role of radiosurgery for brain metastases. Medicines (Basel). 2018;5(3).

Churilla TM, Chowdhury IH, Handorf E, et al. Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2019;5(2):243–7.CrossRef

Rades D, Pluemer A, Veninga T, et al. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer. 2007;110(10):2285–92.CrossRef

Schimmel WCM, Gehring K, Eekers DBP, et al. Cognitive effects of stereotactic radiosurgery in adult patients with brain metastases: a systematic review. Adv Radiat Oncol. 2018;3(4):568–81.CrossRef

Schillaci O, Calabria F, Tavolozza M, et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun. 2010;31(1):39–45.CrossRef

Beheshti M, Haroon A, Bomanji JB, et al. Fluorocholine PET/computed tomography: physiologic uptake, benign findings, and pitfalls. PET Clin. 2014;9(3):299–306.CrossRef

10.

Wyss MT, Weber B, Honer M, et al. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging. 2004;31(3):312–6.CrossRef

11.

van Waarde A, Jager PL, Ishiwata K, et al. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med. 2006;47(1):150–4.PubMed

12.

Mertens K, Bolcaen J, Ham H, et al. The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study. Nucl Med Commun. 2012;33(9):954–9.CrossRef

13.

Bolcaen J, Lybaert K, Moerman L, et al. Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the fiscrimination between high-grade glioma and radiation necrosis in rats. PLoS One. 2016;11(8):e0161845.CrossRef

14.

Minniti G, Scaringi C, Paolini S, et al. Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys. 2016;95(4):1142–8.CrossRef

15.

Dirnagl U. The p value wars (again). Eur J Nucl Med Mol Imaging. 2019;46(12):2421–3.CrossRef

16.

Lohmann P, Kocher M, Ceccon G, et al. Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis. Neuroimage Clin. 2018;20:537–42.CrossRef

17.

Peng L, Parekh V, Huang P, et al. Distinguishing true progression from Radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics. Int J Radiat Oncol Biol Phys. 2018;102(4):1236–43.CrossRef

Titel: Editorial commentary to “18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases” by Grkovski and colleagues
verfasst von: Pierre Lovinfosse
Selma Ben Mustapha
Nadia Withofs
Publikationsdatum: 01.06.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04651-7

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2020

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe

18F-FDG PET/CT and COVID-19

Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse

Correction to: Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas

Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT